Imatinib radiosensitizes bladder cancer by targeting homologous recombination.
Radiotherapy is a major treatment modality used to treat muscle-invasive bladder cancer, with patient outcomes similar to surgery. However, radioresistance is a significant factor in treatment failure. Cell-free extracts of muscle-invasive bladder tumors are defective in nonhomologous end-joining (N...
Үндсэн зохиолчид: | Qiao, B, Kerr, M, Groselj, B, Teo, M, Knowles, M, Bristow, R, Phillips, R, Kiltie, A |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2013
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity.
-н: Choudhury, A, зэрэг
Хэвлэсэн: (2009) -
E3 ligase cIAP2 mediates downregulation of MRE11 and radiosensitization in response to HDAC inhibition in bladder cancer
-н: Nicholson, J, зэрэг
Хэвлэсэн: (2017) -
Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression
-н: Groselj, B, зэрэг
Хэвлэсэн: (2013) -
Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.
-н: Groselj, B, зэрэг
Хэвлэсэн: (2013) -
The HDAC Inhibitor Panobinostat Promotes Expression of Delta 133p53 Variants in TP53 Wild-type Bladder Cancer Cells
-н: Groselj, B, зэрэг
Хэвлэсэн: (2012)